News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
Research News & Stories
Research
Study finds marker of aggressive prostate cancer
The level of a specific molecule present in prostate tumors is an indicator of whether the cancer is aggressive and likely to spread, according to new research from Washington University School of Medicine in St. Louis. The study, available online in the journal European Urology, may inform future clinical tests that help doctors decide how […]
Research
New study shows breast tumors evolve in response to hormone therapy
Many breast tumors grow in response to female hormones, especially estrogen. Drugs that reduce estrogen levels in the body often are effective in reducing tumor size and preventing recurrence of the cancer. But some tumors become resistant to these therapies and continue to grow and spread. A new analysis of breast tumors, before and after […]
In the Media, Research
Potential drug target identified for deadly brain cancer
Glioblastoma is the most common and deadly form of brain cancer in adults, with an average survival time of only 15 months after diagnosis. New research at Washington University School of Medicine in St. Louis provides clues to why some patients with glioblastoma fare worse and identifies a drug target that potentially could improve survival. […]
Research
Study aims to find clues to breast cancer outcomes in African-American women
Scientists’ understanding of the genetic roots of breast cancer is based largely on research conducted in women of European ancestry. That knowledge does little to help explain why African-American women with the disease are more likely to be diagnosed at younger ages and with more aggressive tumors than their white counterparts. They also die of […]
Research
Tissue Procurement Core receives accreditation
The Washington University Tissue Procurement Core, which offers researchers a centralized laboratory to collect, store and use human biospecimens for translational cancer research, has received accreditation by the College of American Pathologists (CAP). The recognition is based on a recent onsite inspection, designed to ensure the highest standards for laboratory operations. “We work hand in […]
In the Media, Research
Treating prostate cancer with precision
The treatment, called focal needle ablation, makes use of a needle that can freeze (cryoablation) or use heat (radiofrequency ablation) to destroy cancer cells. In the past, when a biopsy—the standard diagnostic procedure for the past 20 years—detected a small amount of prostate cancer, it wasn’t known whether the cancer was small or whether the biopsy […]
Research
New clues identified in childhood cancer syndrome
Children with the inherited cancer syndrome neurofibromatosis type 1 (NF1) are prone to developing brain and nerve tumors as well as myriad other medical problems, including autism, epilepsy and bone defects. While the disorder is caused by a mutation in a single gene, the range and severity of clinical abnormalities vary widely, making the impact […]
Clinical, Research
Breast cancer vaccine shows promise in small clinical trial
A breast cancer vaccine developed at Washington University School of Medicine in St. Louis is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression. The study appears Dec. 1 […]
Research
Special glasses help surgeons ‘see’ cancer
High-tech glasses developed at Washington University School of Medicine in St. Louis may help surgeons visualize cancer cells, which glow blue when viewed through the eyewear. The wearable technology, so new it’s yet unnamed, was used during surgery for the first time Feb. 10, 2014 at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School […]
Research
Some deadly breast cancers share genetic features with ovarian tumors
The most comprehensive analysis yet of breast cancer shows that one of the most deadly subtypes is genetically more similar to ovarian tumors than to other breast cancers. The findings, published online Sept. 23 in Nature, suggest that most basal-like breast tumors and ovarian tumors have similar genetic origins and potentially could be treated with […]